There’s not enough evidence that the experimental drug known as aducanumab works, government health advisors said Friday.
New Alzheimer’s drug rejected by FDA panel
- Alton Brown Coming to Greenville’s Peace Center March 1
- Effective Ways For Schools To Improve Their Security
- How Technology Influences the Experience of Music
- 3 Top Tips for Refreshing Your Classroom
- Thank You and Goodbye
- South Carolina Reports 6697 New Covid Infections Friday
- Weekend Things to Do in Greenville South Carolina
- South Carolina Reports 4245 New Covid Infections Thursday
- BMW chairman announces new model to be built in South Carolina
- COVID-19 update from South Carolina DHEC officials
